PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
 
Sci Rep. 2017; 7: 44899.
Published online 2017 March 21. doi:  10.1038/srep44899
PMCID: PMC5359595

A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRAS

Abstract

Haemangioblastoma is a rare malignancy of the CNS where vascular proliferation causes lesions due to endothelial propagation. We found that conditionally expressing mutant Kras, using Rag1-Cre, gave rise to CNS haemangioblastoma in the cortex and cerebellum in mice that present with highly vascular tumours with stromal cells similar to human haemangioblastomas. The aberrant haemangioblastoma endothelial cells do not express mutant Kras but rather the mutant oncogene is expressed in CNS interstitial cells, including neuronal cells and progeny. This demonstrates a non-cell autonomous origin of this disease that is unexpectedly induced via Rag1-Cre expression in CNS interstitial cells. This is the first time that mutant RAS has been shown to stimulate non-cell autonomous proliferation in malignancy and suggests that mutant RAS can control endothelial cell proliferation in neo-vascularisation when expressed in certain cells.

Mouse models of human cancer allow for a better understanding of the cell of origin, the disease process and for therapeutic testing. Many different brain tumours are found in humans of which about 1% are haemangioblastomas that are slow growing and are non-invasive caused by vascular endothelium expansion within brain tissue1. They can be found in the brain stem, cerebellum (the most common form) and in the cerebrum and associated with von Hippel Lindau syndrome2 where it presents in a more malignant form.

There are currently no mouse models of haemangioblastoma in the CNS. We discovered a mouse model of haemangioblastoma in which endothelial cell proliferation occurs to cause deleterious lesions in the brain when we implemented activation of a conditional form of floxed mutant Kirsten Ras (KRas) with glycine 12 mutation to valine (KRasG12V)3 using the VDJ recombinase activating gene 1 (Rag1) to express Cre recombinase4. This was unexpected since the conditional KRas allele was activated by Rag1-Cre expressed in the brain and because the endothelial cells involved do not themselves express the mutant allele of KRas, signifying a non-cell autonomous proliferation causing this disease.

Materials and Methods

Mouse strains and haemangioblastoma pathology

Floxed KRasG12V mice3 were crossed with Rag1-Cre knock in mice4 to generate mice carrying both alleles. When abnormal phenotypes developed, mice were sacrificed by terminal anaesthesia and perfusion fixation. Whole brains were dissected carefully and fixed in 4% paraformaldehyde for 24 hours and equilibrated in 20% sucrose in PBS-0.1%azide at 4 oC overnight. 20 uM sections were prepared on a freezing microtome and stained either with cresyl violet or haematoxylin and Immunohistochemistry carried out with anti-CD31 at 1/20 dilution of rabbit anti-CD31 (Abcam-ab28364) with citric acid antigen retrieval method. All experiments with mice were conducted under a Home Office Personal License and with agreement from the University of Oxford Animal Welfare and Ethical Review Committee.

Reporter gene expression analysis

Rag1-Cre mice were bred with ROSA-tdTomato reporter mice5 and 30 day old heterozygous pups were perfusion fixed with 50 mL 10% buffered formalin after clearing the blood with 50 mL of ice cold PBS supplemented with 1 mM EDTA and the brain removed. Post- dissected whole brains were fixed in ice cold 10% buffered formalin for one hour and submerged in 25% sucrose/PBS overnight. Brains were mounted in tissue freezing medium (Fisher Scientific) and snap frozen on dry ice assisted by freezing aerosol (VWR). Sections were subsequently cut using a Leica cryostat system at 10 μm thickness and allowed to adhere to Superfrost Plus slides (Fisher Scientific) at 37 °C for one hour. Sections were stored for short term at 4 °C before further processing. For microscopy, sections were first mounted in ProLong Gold containing DAPI (Life Technologies) before being viewed using a Zeiss LSM 880 system. Images were captured using tile-scanning at 25x magnification or no tile-scanning at 40x magnification.

Laser capture microdissection (LCM)

LCM was performed using a Zeiss PALM MicroBeam system. Diseased transgenic brains were processed as for pathology and then mounted on special MembraneSlide (Zeiss) slides at a thickness of 7 μm. Before LCM capturing, the slides were de-paraffinised using HistoClear II solution (VWR) twice for 5 minutes each. The slides were allowed to dry completely after dehydration in 100% ethanol twice for 10 minutes each. Different areas of interest were captured in special AdhesiveCap tubes (Zeiss). Extraction of genomic DNA was carried with using a QIAamp DNA FFPE Tissue Kit (Qiagen) according to manufacturer’s instructions. For PCR of the recombined (AG2 band) and non-recombined (GFP band) transgene, a previously described method was used1. High fidelity amplified bands (Q5 polymerase, NEB) were cut from an agarose gel and purified using Qiagen MinElute kit and cloned into Zero-Blunt TOPO vector (Life Technologies) before transformation into chemically competent DH5α E.coli. Three individual clones were selected from Kanamycin plates for each of the AG2 and GFP bands and sequenced using SP6, M13 or T7 primers in the forward and reverse directions. Relevant sequences are shown in Supplementary Fig. 1. Alignment of the sequenced bands with the reference sequence was done using BLAST at NIH.

Results

We discovered a mouse model of haemangioblastoma caused by activation of a conditional form of floxed mutant Kirsten Ras (KRas) with glycine 12 mutation to valine (KRasG12V)3 using the VDJ recombinase activating gene 1 (Rag1) to express Cre recombinase4. Unexpectedly, we observed that the majority of the mice carrying both the floxed KRasG12V gene and the Rag1-Cre (Fig. 1A) developed an abnormal gait and light sensitivity within two months and post-mortem examination revealed hydrocephalus and CNS vascular proliferations with features of haemangioblastoma. The typical phenotypic features were a tendency to be off balance, moving in circles, unstable gate and sensitivity to light. The brains of these animals showed signs of widespread haemorrhage, predominantly in the cerebrum (Fig. 1B,C).

Figure 1
Incidence of haemangioblastoma in mice expressing mutant Kras.

Interbreeding a mouse strain carrying a conditional allele of KRASG12V with a Rag1-Cre strain gave rise to double transgenic mice that developed an abnormal gait in ~80% of individuals with a mean onset at 40 days (Fig. 1D). Histologically the brains show vascular tumours (Fig. 1E,F) that have histopathological features typical of human CNS haemangioblastoma., including variable and irregularly sized blood vessel channels and pseudocystic spaces, lined by endothelial cells with pleomorphic nuclei, with accompanying stromal cells. The mouse model CNS tumour lesions showed a close juxtaposition of endothelial lined capillaries type vessels and stromal cells. The stromal cells often had a pink vacuolated appearance indicative of lipid accumulation, but no stromal cell mitotic figures were seen. The vascular channel lining cells were immunostained positively with anti-mouse CD31 antibody (Fig. 1G,H) confirming detection of endothelial cells forming irregular vascular channels and pseudocystic spaces, (with negatively staining interstitial vacuolated stromal cells), characteristic of haemangioblastomas. The tumours expand and infiltrate into the surrounding brain tissue with destructive effects, resulting in adverse brain functions.

As Rag1 expression is not associated with blood vessel endothelium, we sought evidence of the Cre-activated KrasG12V in isolated endothelial cells using laser capture microscopy (LCM). Endothelial layers from the haemangioblastomas were marked in fixed sections (Fig. 2A) and dissected together with interstitial tissue (Fig. 2A,B shows before & after LCM). Genomic DNA was extracted and PCR carried out with primers that detect the floxed GFP gene and the deleted allele (i.e. activated Kras) following Cre-mediated deletion (and Gapdh as a control) (shown in Fig. 2C). Two separate gDNA LCM isolations were analysed (Fig. 2D), and in both we detected the activated Kras allele in the interstitial cells, but not the floxed allele, whereas the floxed allele was still present in the endothelial cells but not the activated Kras allele. This suggests that the endothelial proliferation is not cell-intrinsic but rather induced by cells in the surrounding tissue that have acquired activated Kras and presumably secreting excitatory molecules.

Figure 2
Laser capture microscopy and genomic PCR from brain endothelial cells.

Since the endothelial expansion is non-cell autonomous, other cells within the brain must be expressing the Rag1-Cre targeted allele. This was examined by employing a reporter mouse strain called ROSA-tdTomato that conditionally expresses the red fluorescent protein Tomato5. Rag1-Cre mice were crossed with ROSA-tdTomato mice, and post-mortem heterogeneous cell staining was found in sections of cerebellum and cerebrum of Rag1-Cre; ROSA-tdTomato double transgenic mice (Fig. 3A,B) but not ROSA-tdTomato-only mice (Fig. 3C,D). Spleens of Rag1-Cre; ROSA-tdTomato double transgenic mice as expected had abundant fluorescent cells (Fig. 3E,F). High power analysis of the cerebrum from the Rag1-Cre; ROSA-tdTomato double transgenic mouse indicated multiple cell types are present in the brain that express the Tomato reporter (Fig. 3G,H).

Figure 3
Heterogeneity of tdTomato reporter gene expression in Rag1-Cre mouse brains.

Discussion

The tumours observed in this mouse model represent the comparative pathological equivalent of human CNS haemangioblastomas with marked histological similarity displaying as highly vascular tumours with stromal cells similar to haemangioblastomas in humans. In a genome wide study of human angiosarcoma, RAS mutations (K, H or NRAS) were found in 5 out of 39 cases but other genes were considered to be aetiological6. In our model, we show using LCM that the Cre-dependent KrasG12V activation does not occur directly in endothelial cells but rather in adjacent cells that express growth factors to drive vascular endothelial proliferation by a paracrine mechanism.

Although the exact identity of these cells is unknown, candidates are CNS cells that have Rag1 expression during development7. Cells in the brain that express the Rag-1 gene cause activation of the mutant Kras in this mouse model and that are responsible for the angiogenic effects we observe giving stimulus to the endothelial lesions. Astrocytes have been shown to secrete vascular endothelial growth factor (VEGF) in post-natal brains8,9 and VEGF secretion can be stimulated in cells by activation of mutant KRAS10. Non-haematopoietic expression of Rag1 in brain cells remains controversial but our results support the hypothesis that Rag1 is important in brain function. Our work suggests a further study should be undertaken to establish the roles of Rag1 in brain biology and of VEGF-VEGFR interaction in CNS haemangioblastoma. The observation that mutant RAS expressing cells can induce endothelial cell proliferation also has important potential implications for angiogenesis in solid tumour growth where neo-vascularisation enhances tumour growth and supports dissemination of disease to create metastasis. In turn, the metastatic deposits, themselves carrying mutant RAS, could engender neo-vascularisation to sustain their own expansion.

Additional Information

How to cite this article: Bao, L. et al. A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRAS. Sci. Rep. 7, 44899; doi: 10.1038/srep44899 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Material

Supplementary Information:

Acknowledgments

We would like to thank Prof. Anton Berns for the conditional Kras mice. This work was supported by grants from the Medical Research Council (MR/J000612/1), the Wellcome Trust (099246/Z/12/Z) and Bloodwise (12051).

Footnotes

The authors declare no competing financial interests.

Author Contributions Originator of project: T.H.R. Participated in research design: T.H.R., O.A.A., R.A.B. and M.J.A. Conducted experiments: L.B., O.A.A., L.F.D., M.J.A. and P.T. Performed data analysis: T.H.R., R.A.B., L.B., O.A.A. and M.J.A. Wrote or contributed to the writing of the manuscript: All authors.

References

  • Cushing H. & Bailey P. Hemangiomas of Cerebellum and Retina (Lindau’s Disease): With the Report of a Case. Trans Am Ophthalmol Soc 26, 182–202 (1928). [PMC free article] [PubMed]
  • Neumann H. P. et al. . Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55, 898–901 (1992). [PMC free article] [PubMed]
  • Meuwissen R., Linn S. C., van der Valk M., Mooi W. J. & Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 20, 6551–6558, doi: (2001).10.1038/sj.onc.1204837 [PubMed] [Cross Ref]
  • McCormack M. P., Forster A., Drynan L., Pannell R. & Rabbitts T. H. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol 23, 9003–9013 (2003). [PMC free article] [PubMed]
  • Madisen L. et al. . A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13, 133–140, doi: (2010).10.1038/nn.2467 [PMC free article] [PubMed] [Cross Ref]
  • Behjati S. et al. . Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet 46, 376–379, doi: (2014).10.1038/ng.2921 [PMC free article] [PubMed] [Cross Ref]
  • Chun J. J., Schatz D. G., Oettinger M. A., Jaenisch R. & Baltimore D. The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system. Cell 64, 189–200 (1991). [PubMed]
  • Argaw A. T. et al. . Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122, 2454–2468, doi: (2012).10.1172/JCI60842 [PMC free article] [PubMed] [Cross Ref]
  • Verkhratsky A., Matteoli M., Parpura V., Mothet J. P. & Zorec R. Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. EMBO J 35, 239–257, doi: (2016).10.15252/embj.201592705 [PubMed] [Cross Ref]
  • Matsuo Y. et al. . K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways. Mol Cancer Res 7, 799–808, doi: (2009).10.1158/1541-7786.MCR-08-0577 [PMC free article] [PubMed] [Cross Ref]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group